Articles
Type 2 MI and Myocardial Injury in the Era of High-sensitivity Troponin
Published:
17 February 2022
Citation:
European Cardiology Review 2022;17:e03.
Valvular Heart Disease in Patients with Chronic Kidney Disease
Published:
31 January 2022
Citation:
European Cardiology Review 2022;17:e02
The 2021 European Heart Failure Guidelines
Published:
28 January 2022
Citation:
European Cardiology Review 2022;17:e01.
The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis
Published:
14 December 2021
Citation:
European Cardiology Review 2021;16:e70.
25th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
Published:
14 December 2021
Citation:
European Cardiology Review 2021;16:e56.
Early Initiation of Tolvaptan is Associated with Early Discharge in Elderly Heart Failure Patients
Published:
14 December 2021
Citation:
European Cardiology Review 2021;16:e67.
A Novel Curcumin Formulation, ASD-Cur, Suppressed the Development of Systolic Dysfunction After Myocardial Infarction in Rats
Published:
14 December 2021
Citation:
European Cardiology Review 2021;16:e69.
Retrospective Study to Assess the Effect of Telmisartan on Urine Albumin to Creatinine Ratio in Indian Hypertensive Patients
Published:
14 December 2021
Citation:
European Cardiology Review 2021;16:e63.
Prevalence of Aspirin and Clopidogrel Resistance in Patients with Recurrent Ischaemic Cerebrovascular Disease
Published:
14 December 2021
Citation:
European Cardiology Review 2021;16:e72.
The Role of Isocitrate Dehydrogenases in Direct Reprogramming to Cardiomyocytes
Published:
14 December 2021
Citation:
European Cardiology Review 2021;16:e64.